<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126083">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01927874</url>
  </required_header>
  <id_info>
    <org_study_id>Bl.Pud</org_study_id>
    <nct_id>NCT01927874</nct_id>
  </id_info>
  <brief_title>Subarachnoid or Infiltration for Hemorrhoidectomy</brief_title>
  <official_title>Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There will be compared the postoperative analgesic effect of infiltration or spinal block
      for hemorrhoidectomy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized study, including 40 patients between 18 and 60 years, of
      both genders, ASA 1 or 2.

      Patients in group 1 (n = 20) will be submitted to spinal block and group 2 (n = 20) to
      infiltration. The spinal block will be performed with 10 mg of 0.5% bupivacaine. The
      infiltration will be performed with 10 ml of 0.5% bupivacaine with epinephrine on each side.

      Will be evaluated: intensity of pain on a numerical scale from 0 to 10 every 15 minutes,
      relaxation of the sphincter muscles, intensity of pain after the operation every 30 minutes
      until reached the criteria for discharge, muscle strength of the lower limbs every 30
      minutes, BP, HR, SO2, FR, other items that determine the conditions of discharge (urine
      output, nausea and vomiting), time to hospital discharge, and duration of analgesia. Adverse
      effects and complications will be noted.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Numerical score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to discharge</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of motor blockade</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hemorrhoid</condition>
  <arm_group>
    <arm_group_label>Infiltration, analgesic effect</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10ml 0.5% bupivacaine each side Block Injection of local anesthetic at pudendal nerve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 mg of hyperbaric 0.5% bupivacaine Injection of anesthetic at subarachnoidal space</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Infiltration</intervention_name>
    <description>injection of local anesthetic</description>
    <arm_group_label>Infiltration, analgesic effect</arm_group_label>
    <other_name>Local Infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal block</intervention_name>
    <description>injection of anesthetic</description>
    <arm_group_label>Spinal block</arm_group_label>
    <other_name>subarachnoidal block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>10ml 0.5% bupivacaine. Injection of local anesthetic around the nerve</description>
    <arm_group_label>Infiltration, analgesic effect</arm_group_label>
    <other_name>Local infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10 mg of hyperbaric 0.5% bupivacaine</intervention_name>
    <arm_group_label>Spinal block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Will be included 50 patients, ASA physical status 1 or 2 undergoing hemorrhoidectomy
             after approval by the Ethics Committee and signed Consent Form

        Exclusion Criteria:

          -  There will be excluded patients with associated diseases (fistula, fissure),
             infection at the puncture site, using anticoagulants or analgesics (up to 2 weeks
             before the procedure) and pregnant.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rioko K Sakata, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rioko K Sakata, PhD</last_name>
    <phone>055 11 50847463</phone>
    <email>riokoks.dcir@epm.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universidade Federal de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04044020</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rioko K Sakata, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Adriana M Issy, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Rioko K Sakata, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 24, 2014</lastchanged_date>
  <firstreceived_date>August 23, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Rioko Kimiko Sakata</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Pudendal block</keyword>
  <keyword>hemorrhoidectomy</keyword>
  <keyword>Postoperative pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
